Andrew Fisher

CIK 2014301 · General Counsel · last filed 2025-10-08

Andrew Fisher is a General Counsel who has filed 10 SEC Form 4 insider transactions across 1 company since 2024. The most recent filing, for VRNA, was dated Oct 8, 2025. Across all open-market trades the lifetime net is −$2.0M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

10

Lifetime Open-Market Net

-$1.97M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Verona Pharma plc (VRNA) Delisted General Counsel 931,984 $106.91 $99.64M -$1.97M 9 2025-10-08

Recent Filings

10 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-10-08 Verona Pharma plc (VRNA) Delisted Mixed −417,903 $0 EDGAR
2025-08-05 Verona Pharma plc (VRNA) Delisted Mixed +11,304 -$126.0K EDGAR
2025-07-09 Verona Pharma plc (VRNA) Delisted Mixed +46,600 -$451.5K EDGAR
2025-06-18 Verona Pharma plc (VRNA) Delisted Mixed -$761.1K EDGAR
2025-06-18 Verona Pharma plc (VRNA) Delisted Exer (M) +80,000 $160.9K EDGAR
2025-05-16 Verona Pharma plc (VRNA) Delisted Mixed -$516.6K EDGAR
2025-05-15 Notice (144) −30,000 -$2.02M EDGAR
2025-05-01 Verona Pharma plc (VRNA) Delisted Mixed +59,993 -$234.1K EDGAR
2024-11-01 Verona Pharma plc (VRNA) Delisted Grant (A) +300,000 $0 EDGAR
2024-04-02 Verona Pharma plc (VRNA) Delisted Grant (A) $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.